Congenital heart defects, the most common birth anomalies worldwide, claim the lives of roughly 180,000 to 200,000 newborns in India every year, and a sweeping new analysis suggests the country is losing ground in the fight against a largely survivable condition. Using three decades of data from the Global Burden of Disease 2021 study, researchers have quantified for the first time how India’s progress on heart-related infant mortality has lagged behind the rest of the world, and what that failure costs the nation in economic terms.
The study, published in Pediatric Research by Ramesh Vidavalur of Cayuga Medical Center and Weill Cornell Medical College, Ramesh Agarwal of the All India Institute of Medical Sciences in New Delhi, and Vinod K. Bhutani of Stanford University School of Medicine, examined trends in congenital heart disease related infant and neonatal mortality in India from 1990 to 2021. The findings are stark: of the approximately 8.6 million infants worldwide who died from congenital heart defects over that 31-year period, about 1.5 million were Indian, representing roughly 18 percent of the entire global burden.
Congenital heart defects affect approximately 9 per 1,000 live births in India, a prevalence consistent with global estimates but applied to one of the world’s largest birth cohorts. Because most critical lesions manifest within the first days or weeks of life, congenital heart disease has become an increasingly visible share of India’s residual infant mortality as other causes, such as infections and prematurity complications, decline. Yet the analysis shows the country’s response has not kept pace.
Between 1990 and 2021, India’s congenital heart disease related neonatal mortality declined at an annual rate of just 1.5 percent, significantly slower than the global rate of 2.2 percent per year. That gap, compounded over three decades, means the relative weight of congenital heart disease within India’s infant mortality profile has grown even as absolute numbers of deaths have fallen.
The segmental analysis reveals a more troubling pattern beneath the long-term trend. Progress stagnated almost entirely between 2003 and 2013, a decade in which mortality reduction essentially flatlined. Only in recent years did the pace of decline recover, with a nearly threefold acceleration observed between 2019 and 2021. The researchers suggest this late acceleration may reflect expanding neonatal care infrastructure and growing recognition of critical congenital heart disease, but they caution that the gains remain fragile and unevenly distributed.
Indeed, subnational analysis identified substantial inequities in mortality reduction across Indian states. States with stronger health systems, better access to pediatric cardiac surgery, and more developed newborn screening programs achieved far greater declines than those where diagnosis is often delayed until infants arrive at referral centers in critical condition. Prior studies from South India have shown that transport delays alone dramatically worsen outcomes for newborns with heart disease, a problem concentrated in lower-income and rural regions.
The economic toll is enormous. Applying human capital and value of statistical life frameworks, the authors estimated that congenital heart disease related infant deaths cost India approximately 11.7 billion US dollars in lost economic value in 2021 alone, with a plausible range of 9 to 12 billion dollars. Each infant death from a treatable cardiac defect represents not only a family tragedy but also decades of lost productive capacity, underscoring that investment in early detection and surgical capacity is not merely a health priority but an economic one.
The contrast with high-income countries is instructive. In the United States, the rollout of mandatory pulse oximetry screening for critical congenital heart disease in newborn nurseries has been associated with measurable reductions in early infant cardiac deaths. Randomized and observational evidence has also shown that prenatal diagnosis substantially lowers the risk of death from cardiovascular collapse before planned surgery. India has validated pulse oximetry screening in its own newborn populations and issued national consensus guidelines on the timing of intervention, but implementation across public facilities remains patchy.
The authors argue that sustaining and accelerating the recent gains will require system-level reform on several fronts simultaneously: expanding pediatric cardiology and cardiac surgery training, improving service delivery in public healthcare facilities where most Indian children are treated, strengthening national surveillance so that the true burden is no longer obscured by sparse mortality data, and building longitudinal follow-up for children who survive initial interventions. Kerala’s population-based approach to congenital heart disease offers one domestic model of what coordinated, state-level planning can achieve.
As India pursues its sustainable development targets for child survival, the study makes clear that congenital heart disease is no longer a marginal contributor that can be deferred. With nearly one in five global deaths from these defects occurring in India, closing the gap between Indian and global rates of improvement could save tens of thousands of lives each year and unlock billions of dollars in economic value, provided the political will matches the scale of the problem.
Subject of Research: Trends and economic impact of infant mortality from congenital heart disease in India, 1990–2021
Article Title: Burden, trends and economic impact of infant mortality from congenital heart diseases in India, 1990–2021
Article References: Vidavalur, R., Agarwal, R., & Bhutani, V. K. (2026). Burden, trends and economic impact of infant mortality from congenital heart diseases in India, 1990–2021. Pediatric Research. https://doi.org/10.1038/s41390-026-05430-5
Image Credits: AI Generated
DOI: 10.1038/s41390-026-05430-5
Keywords: congenital heart disease, infant mortality, neonatal mortality, India, Global Burden of Disease, pediatric cardiology, economic burden, newborn screening, health inequity, pulse oximetry, neonatal care, Pediatric Research
Cite Scienmag News
APA
MLA
Chicago
Harold Sullivan. (September 20, 2026). India bears nearly a fifth of global infant deaths from congenital heart disease. Scienmag. https://scienmag.com/india-bears-nearly-a-fifth-of-global-infant-deaths-from-congenital-heart-disease/
Harold Sullivan. “India bears nearly a fifth of global infant deaths from congenital heart disease.” Scienmag, 20 September 2026, https://scienmag.com/india-bears-nearly-a-fifth-of-global-infant-deaths-from-congenital-heart-disease/. Accessed 20 September 2026.
Harold Sullivan. “India bears nearly a fifth of global infant deaths from congenital heart disease.” Scienmag. September 20, 2026. https://scienmag.com/india-bears-nearly-a-fifth-of-global-infant-deaths-from-congenital-heart-disease/
Copy citation
Download RIS
Tags: congenital heart diseaseCongenital heart disease in Indiaeconomic burdeneconomic impact of infant deathsglobal burden of congenital heart defectsglobal burden of diseaseglobal comparison of infant mortalityhealth inequityhealthcare challenges in Indiahealthcare disparities in IndiaIndiaIndia neonatal mortality ratesinfant mortalityinfant mortality from birth defectslong-term effects of congenital heart defectsneonatal careneonatal mortalitynewborn screeningpediatric cardiologypediatric heart care in Indiapediatric researchpulse oximetrysurvival rates of congenital heart defectstrends in congenital heart disease
